Literature DB >> 17022199

Point/Counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation.

John F Fowler1, Alan E Nahum, Colin G Orton.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17022199     DOI： 10.1118/1.2179008

Source DB:  PubMed          Journal:  Med Phys        ISSN： 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  3 in total

1.  Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.

Authors:  Mark Ritter
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

2.  Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.

Authors:  Antonella Bufacchi; Barbara Nardiello; Roberto Capparella; Luisa Begnozzi
Journal:  Radiat Oncol       Date:  2013-07-04       Impact factor: 3.481

Review 3.  Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits.

Authors:  K J Ray; N R Sibson; A E Kiltie
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-03-07       Impact factor: 4.126
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.